Informed Consent for Whole Genome Sequencing
Insights from Paul Appelbaum, MD, Columbia University Medical Center
Wednesday, January 29, 2014
Okagaki Room, University Hospital
Whole genome and whole exome sequencing are becoming prevalent tools in clinical medicine and medical research. Dr. Paul Applebaum will explore possible new models of informed patient consent that will be needed in this emerging field. Applebaum, former president of the American Psychiatric Association, is one of the world’s leading experts on informed consent in medicine.